Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Montgomery is now accepting applications for a new workforce program aimed at helping young adults who left school early get ...

Patients can now access exclusive discounts and new personalized wellness programs designed to support long-term health goals ...

The comprehensive review Michael Alford promised when FSU announced it would retain Mike Norvell is now in full swing. Here's ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Adeptify announces the launch of a leadership development program designed to strengthen managers’ clarity, capability, and ...

NEW YORK and DAEJEON, South Korea, Dec. 11, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating ...

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...

It is the predictable tipping point faced by many high-growth African businesses whose founders are juggling scale ...

The USDA says farmers have until 5 p.m. ET on Dec. 19 to apply. Those who qualify will receive payments by the end of ...

The issue with Trump's farm bailout, some farmers and economists are quick to note, is that the problems facing farmers are ...